Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 52

Cited In for PubMed (Select 18042936)

2.

Lifetime and 5 years risk of breast cancer and attributable risk factor according to Gail model in Iranian women.

Mohammadbeigi A, Mohammadsalehi N, Valizadeh R, Momtaheni Z, Mokhtari M, Ansari H.

J Pharm Bioallied Sci. 2015 Jul-Sep;7(3):207-11. doi: 10.4103/0975-7406.160020.

3.

Chemoprevention for Breast Cancer.

Pruthi S, Heisey RE, Bevers TB.

Ann Surg Oncol. 2015 Oct;22(10):3230-5. doi: 10.1245/s10434-015-4715-9. Epub 2015 Jul 23.

4.

Breast Cancer Risk Assessment Among Low-Income Women of Color in Primary Care: A Pilot Study.

Anderson EE, Tejeda S, Childers K, Stolley MR, Warnecke RB, Hoskins KF.

J Oncol Pract. 2015 Jul;11(4):e460-7. doi: 10.1200/JOP.2014.003558. Epub 2015 Jun 2.

PMID:
26036266
5.

An exercise trial targeting African-American women with metabolic syndrome and at high risk for breast cancer: Rationale, design, and methods.

Dash C, Makambi K, Wallington SF, Sheppard V, Taylor TR, Hicks JS, Adams-Campbell LL.

Contemp Clin Trials. 2015 Jul;43:33-8. doi: 10.1016/j.cct.2015.04.015. Epub 2015 May 8.

PMID:
25962889
6.

Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.

Reimers LL, Sivasubramanian PS, Hershman D, Terry MB, Greenlee H, Campbell J, Kalinsky K, Maurer M, Jayasena R, Sandoval R, Alvarez M, Crew KD.

Breast J. 2015 Jul;21(4):377-86. doi: 10.1111/tbj.12418. Epub 2015 Apr 16.

PMID:
25879521
7.

JNCI and cancer prevention.

Dunn BK, Ghosh S, Kramer BS.

J Natl Cancer Inst. 2015 Feb 24;107(3). pii: djv021. doi: 10.1093/jnci/djv021. Print 2015 Mar.

PMID:
25713150
8.

Prospective approach to breast cancer risk prediction in African American women: the black women's health study model.

Boggs DA, Rosenberg L, Adams-Campbell LL, Palmer JR.

J Clin Oncol. 2015 Mar 20;33(9):1038-44. doi: 10.1200/JCO.2014.57.2750. Epub 2015 Jan 26.

PMID:
25624428
9.

Risk-benefit profiles of women using tamoxifen for chemoprevention.

Nichols HB, DeRoo LA, Scharf DR, Sandler DP.

J Natl Cancer Inst. 2014 Dec 3;107(1):354. doi: 10.1093/jnci/dju354. Print 2015 Jan.

PMID:
25475563
10.

Current strategies for the prevention of breast cancer.

Advani P, Moreno-Aspitia A.

Breast Cancer (Dove Med Press). 2014 May 2;6:59-71. doi: 10.2147/BCTT.S39114. eCollection 2014. Review.

11.

Assessing the goodness of fit of personal risk models.

Gong G, Quante AS, Terry MB, Whittemore AS.

Stat Med. 2014 Aug 15;33(18):3179-90. doi: 10.1002/sim.6176. Epub 2014 Apr 22.

12.

Mammographic breast density as a risk factor for breast cancer: awareness in a recently screened clinical sample.

O'Neill SC, Leventhal KG, Scarles M, Evans CN, Makariou E, Pien E, Willey S.

Womens Health Issues. 2014 May-Jun;24(3):e321-6. doi: 10.1016/j.whi.2014.02.005. Epub 2014 Apr 13.

13.

Perceived versus objective breast cancer risk in diverse women.

Fehniger J, Livaudais-Toman J, Karliner L, Kerlikowske K, Tice JA, Quinn J, Ozanne E, Kaplan CP.

J Womens Health (Larchmt). 2014 May;23(5):420-7. doi: 10.1089/jwh.2013.4516. Epub 2013 Dec 28.

14.

Common breast cancer risk variants in the post-COGS era: a comprehensive review.

Maxwell KN, Nathanson KL.

Breast Cancer Res. 2013 Dec 20;15(6):212. doi: 10.1186/bcr3591. Review.

15.

Patterns of breast magnetic resonance imaging use in community practice.

Wernli KJ, DeMartini WB, Ichikawa L, Lehman CD, Onega T, Kerlikowske K, Henderson LM, Geller BM, Hofmann M, Yankaskas BC; Breast Cancer Surveillance Consortium.

JAMA Intern Med. 2014 Jan;174(1):125-32. doi: 10.1001/jamainternmed.2013.11963.

16.

Korean risk assessment model for breast cancer risk prediction.

Park B, Ma SH, Shin A, Chang MC, Choi JY, Kim S, Han W, Noh DY, Ahn SH, Kang D, Yoo KY, Park SK.

PLoS One. 2013 Oct 25;8(10):e76736. doi: 10.1371/journal.pone.0076736. eCollection 2013.

17.

Tamoxifen vs Raloxifene vs Exemestane for Chemoprevention.

Reimers L, Crew KD.

Curr Breast Cancer Rep. 2012 Sep 1;4(3):207-215.

18.

Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.

Pfeiffer RM, Park Y, Kreimer AR, Lacey JV Jr, Pee D, Greenlee RT, Buys SS, Hollenbeck A, Rosner B, Gail MH, Hartge P.

PLoS Med. 2013;10(7):e1001492. doi: 10.1371/journal.pmed.1001492. Epub 2013 Jul 30.

19.

Impact of correlation on predictive ability of biomarkers.

Demler OV, Pencina MJ, D'Agostino RB Sr.

Stat Med. 2013 Oct 30;32(24):4196-210. doi: 10.1002/sim.5824. Epub 2013 May 3.

20.

Belief in numbers: When and why women disbelieve tailored breast cancer risk statistics.

Scherer LD, Ubel PA, McClure J, Greene SM, Alford SH, Holtzman L, Exe N, Fagerlin A.

Patient Educ Couns. 2013 Aug;92(2):253-9. doi: 10.1016/j.pec.2013.03.016. Epub 2013 Apr 24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk